Press Releases

Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors


Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first FDA-cleared and CE-marked wearable watch for the objective treatment and management of Parkinson’s disease, called the Personal KinetiGraph® (PKG®), today announced the appointment of Gregory Barrett, a distinguished medical device industry expert, as an independent director to its Board of Directors. 


Please read full press release here

Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy

Global Kinetics Corporation Ltd., in conjunction with the Parkinson’s Institute and Clinical Center, today announced the publication of a joint study in the Journal of Parkinson’s Disease. Study authors concluded that the Personal KinetiGraph® (PKG®), a wearable device that precisely monitors, quantifies, and reports movement symptoms in patients with Parkinson’s disease (PD), provided additional information beyond that which is typically captured during routine clinical visits.


Please read full press release here